跳到正文
原文
Endpoints News 生物医药· Lei Lei Wu·· 28 天前精选AI 评分66

BMS披露多发性硬化CAR-T试验死亡,解释狼疮试验安全信号

Bristol Myers reveals death in MS CAR-T trial, has answer for safety signal in lupus trial

AI 导读

布法罗研究所进行的自身免疫CAR-T试验中一名患者死亡,该技术今夏因系统性红斑狼疮试验出现安全信号受到关注。原文未提供试验细节与死亡原因说明。

推荐理由

原文披露布法罗研究患者死亡及安全信号,有助于了解自身免疫CAR-T疗法的风险进展。

正文 · 原文

A pa­tient has died in a Bris­tol My­ers Squibb study of au­toim­mune CAR-T, the same tech­nol­o­gy that was called in­to ques­tion this sum­mer when both …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news